Ergoteles »

Vertex Pharmaceuticals Incorporated shares owned by Ergoteles

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Ergoteles from 13F filings

Historical chart of Ergoteles investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Ergoteles consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Ergoteles

Quarter filed Position value Share count Share price at filing
2023-03-31 $3.2M 10k 315.07
2022-12-31 $1.9M 6.6k 288.78
2021-06-30 $8.3M 41k 201.62
2020-12-31 $936k 4.0k 236.30

More positions owned by Ergoteles

Activision Blizzard
Horizon Therapeutics Pub L SHS
National Instruments
Vmware Cl A Com
ARGO GROUP INTERNATIONAL Holdi Com Stk
Provident Financial Services (PFS)
Amedisys (AMED)
Lakeland Ban (LBAI)
Neogames S A SHS (NGMS)
Midwest Hldg Com New
Greenhill & Co
Eneti
Ishares Tr China Lg-cap Etf (FXI)
Ishares Tr Ishares Biotech (IBB)
Denbury

View all positions for Ergoteles

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated